Les nouveaux traitements des maladies inflammatoires chroniques de l’intestin

Amélie Barré(Hôpital Cochin), Véred Abitbol(Hôpital Cochin), Julie Lavolé(Hôpital Cochin), Solène Dermine(Hôpital Cochin), Romain Coriat(Hôpital Cochin), Stanislas Chaussade(Hôpital Cochin), Georgia Malamut(Délégation Paris 5), Lola‐Jade Palmieri(Hôpital Cochin)

La Presse Médicale Formation

March 1, 2020

10.1016/j.lpmfor.2020.03.011

Cited by 0

Related Papers

Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia

|New England Journal of Medicine|2011|852

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial1 1The authors thank the women and men who participated in the study, P. E. Douziech for coordination of treatments, and the hospital pharmacists for preparation of the treatments in the trial centers.

|Gastroenterology|2003|395

Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II

|Gastroenterology|2008|378

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

|The Journal of Experimental Medicine|2007|310

The Enteropathy Associated With Common Variable Immunodeficiency: The Delineated Frontiers With Celiac Disease

|The American Journal of Gastroenterology|2010|297